TrademarkDir
EPTUZIL
DEAD

Serial Number

85919892

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

May 1, 2013

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

EPTUZIL Trademark

Serial Number: 85919892

EPTUZIL is a trademark filed by NOVARTIS AG on May 1, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,170 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 1, 2013

Registration Date

Not Registered

Published for Opposition

September 24, 2013

Goods & Services

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Dec 27, 2016 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 26, 2016 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 21, 2016 EXRA
SOU EXTENSION 5 GRANTED
May 20, 2016 EX5G
SOU EXTENSION 5 FILED
May 17, 2016 EXT5
SOU TEAS EXTENSION RECEIVED
May 17, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 19, 2015 EXRA
SOU EXTENSION 4 GRANTED
Nov 18, 2015 EX4G
SOU EXTENSION 4 FILED
Nov 16, 2015 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 16, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 19, 2015 EXRA
SOU EXTENSION 3 GRANTED
May 16, 2015 EX3G
SOU EXTENSION 3 FILED
May 15, 2015 EXT3
SOU TEAS EXTENSION RECEIVED
May 15, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 9, 2015 EXRA
SOU EXTENSION 2 GRANTED
Jan 8, 2015 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 8, 2015 AITU
SOU EXTENSION 2 FILED
Nov 15, 2014 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 15, 2014 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 20, 2014 EXRA
SOU EXTENSION 1 GRANTED
May 17, 2014 EX1G
SOU EXTENSION 1 FILED
May 17, 2014 EXT1
SOU TEAS EXTENSION RECEIVED
May 17, 2014 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 19, 2013 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 24, 2013 NPUB
PUBLISHED FOR OPPOSITION
Sep 24, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 4, 2013 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 13, 2013 CNSA
ASSIGNED TO EXAMINER
Aug 12, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 8, 2013 NWOS
NEW APPLICATION ENTERED
May 4, 2013 NWAP

Related Trademarks

More from this Owner

VAYBETRY

VAYBETRY

BEXJUXI

BEXJUXI

VOBYXA

VOBYXA

VISANSTA

VISANSTA

VISANSTA

VISANSTA

VOBYXA

VOBYXA